1. Alousi AA, Grant AM, Etzler JR, Cofer BR, Van der Bel-Kahn J, Melvin D (1990) Reduced cardiac myofibrillar Mg-ATPase activity without changes in myosin isozymes in patients with end-stage heart failure. Mol Cell Biochem 96: 79–88
2. Alpert NR, Gordon MS (1962) Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am J Physiol 202: 940–946
3. Auckland LM, Lambert SJ, Cummins P (1986) Cardiac myosin light and heavy chain isotypes in tetralogy of Fallot. Cardiovasc Res 20: 828–836
4. Bober E, Buchberger-Seidl A, Braun T, Singh S, Goedde HW, Arnold HH (1990) Identification of three developmentally controlled isoforms of human myosin heavy chains. Eur J Biochem 189: 55–65
5. Böhm M, Morano I, Pieske B, Rüegg JC, Wankerl M, Zimmermann R, Erdmann E (1991) Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 68: 689–701